4D Molecular Therapeutics Inc. (FDMT) NASDAQ
$25.66 0.08 (0.31%)
Market Cap: $1.32B
As of 05/16/24 03:59 PM EDT. Market closed.
4D Molecular Therapeutics Inc. (FDMT)
NASDAQ
$25.66
0.08 (0.31%)
Market Cap: $1.32B
As of 05/16/24 03:59 PM EDT. Market closed.
Add to Portfolio
the mission of 4d molecular therapeutics is to design and develop transformative gene therapy products using our proprietary technology to create novel adeno-associated virus variants to be utilized as treatments for serious unmet medical conditions. our products are unlocking the full potential of gene therapy to treat, and potentially cure, genetic diseases. a large number of patients and ... read more
COMPANY PROFILE
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Full Time Employees
141
Address
.
PRICE CHART FOR 4D MOLECULAR THERAPEUTICS INC
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$25.16
Previous Close
$25.58
Days Range
$25.50 - $27.17
52 week range
$9.44 - $36.25
Volume
526,900
Avg. Volume (30 days)
431,044
Market Cap
$1.32B
Dividend Yield
-
P/E
(12.65)
Shares Outstanding
51,703,412
Open
$25.16
Previous Close
$25.58
Days Range
$25.50 - $27.17
52 week range
$9.44 - $36.25
Volume
526,900
Avg. Volume (30 days)
431,044
Market Cap
$1.32B
Dividend Yield
-
P/E
(12.65)
Shares Outstanding
51,703,412
FINANCIAL STATEMENTS FOR 4D MOLECULAR THERAPEUTICS INC
LOADING...
INSIDER TRANSACTIONS FOR 4D MOLECULAR THERAPEUTICS INC
Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
Bizily Scott | Chief Legal Officer | Apr 16, 2024 | Option Exercise | $7.60 | 1,750 | 13,295 | 3,487 | Apr 18, 2024, 08:48 PM |
Bizily Scott | Chief Legal Officer | Apr 16, 2024 | Sale | $25.74 | 1,750 | 45,045 | 1,737 | Apr 18, 2024, 08:48 PM |
Bizily Scott | Chief Legal Officer | Apr 01, 2024 | Option Exercise | $12.54 | 8,153 | 102,224 | 9,890 | Apr 03, 2024, 07:18 PM |
Bizily Scott | Chief Legal Officer | Apr 01, 2024 | Sale | $31.78 | 8,153 | 259,102 | 1,737 | Apr 03, 2024, 07:18 PM |
Bizily Scott | Chief Legal Officer | Mar 27, 2024 | Option Exercise | $25.98 | 5,833 | 151,541 | 7,570 | Mar 29, 2024, 04:52 PM |
Bizily Scott | Chief Legal Officer | Mar 27, 2024 | Sale | $35.04 | 5,833 | 204,410 | 1,737 | Mar 29, 2024, 04:52 PM |
Bizily Scott | Chief Legal Officer | Mar 18, 2024 | Option Exercise | $7.60 | 1,750 | 13,295 | 3,487 | Mar 20, 2024, 04:40 PM |
Bizily Scott | Chief Legal Officer | Mar 18, 2024 | Sale | $31.27 | 1,750 | 54,723 | 1,737 | Mar 20, 2024, 04:40 PM |
Bizily Scott | Chief Legal Officer | Feb 27, 2024 | Option Exercise | $20.24 | 1,909 | 38,638 | 3,646 | Feb 29, 2024, 06:01 PM |
Bizily Scott | Chief Legal Officer | Feb 27, 2024 | Sale | $30.00 | 1,909 | 57,270 | 1,737 | Feb 29, 2024, 06:01 PM |
Bizily Scott | Chief Legal Officer | Feb 16, 2024 | Option Exercise | $7.60 | 1,750 | 13,295 | 3,487 | Feb 21, 2024, 05:41 PM |
Bizily Scott | Chief Legal Officer | Feb 16, 2024 | Sale | $27.67 | 1,750 | 48,423 | 1,737 | Feb 21, 2024, 05:41 PM |
Bizily Scott | Chief Legal Officer | Feb 08, 2024 | Option Exercise | $10.18 | 6,244 | 63,586 | 4,653 | Feb 12, 2024, 09:04 PM |
Bizily Scott | Chief Legal Officer | Feb 08, 2024 | Sale | $27.50 | 6,244 | 171,710 | 1,737 | Feb 12, 2024, 09:04 PM |
Kirn David | Chief Executive Officer | Feb 08, 2024 | Sale | $27.13 | 92,001 | 2,495,822 | 1,059,153 | Feb 12, 2024, 08:22 PM |
Kim Robert Young | Chief Medical Officer | Feb 05, 2024 | Option Exercise | $15.28 | 24,000 | 366,840 | 13,595 | Feb 07, 2024, 08:32 PM |
Kim Robert Young | Chief Medical Officer | Feb 05, 2024 | Sale | $30.05 | 24,552 | 737,788 | 1,595 | Feb 07, 2024, 08:32 PM |
Kirn David | Chief Executive Officer | Jan 23, 2024 | Sale | $18.41 | 5,696 | 104,851 | 1,151,154 | Jan 25, 2024, 04:59 PM |
Kirn David | Chief Executive Officer | Jan 05, 2024 | Sale | $19.57 | 28,237 | 552,478 | 1,156,983 | Jan 08, 2024, 04:19 PM |
Kirn David | Chief Executive Officer | Jan 04, 2024 | Sale | $20.31 | 40,732 | 827,202 | 1,185,087 | Jan 08, 2024, 04:19 PM |
Kirn David | Chief Executive Officer | Dec 18, 2023 | Sale | $18.13 | 4,702 | 85,243 | 1,225,819 | Jan 08, 2024, 04:19 PM |
Kirn David | Chief Executive Officer | Dec 15, 2023 | Sale | $17.27 | 28,632 | 494,432 | 1,230,521 | Jan 08, 2024, 04:19 PM |
VIKING GLOBAL INVESTORS LP | 10% Owner | Jan 04, 2024 | Sale | $19.53 | 540,000 | 10,546,200 | 4,247,914 | Jan 05, 2024, 05:44 PM |
Bizily Scott | Chief Legal and HR Officer | Jun 08, 2023 | Option Exercise | $8.04 | 3,750 | 30,150 | 5,487 | Jun 12, 2023, 06:23 PM |
Bizily Scott | Chief Legal and HR Officer | Jun 08, 2023 | Sale | $20.85 | 3,750 | 78,188 | 1,737 | Jun 12, 2023, 06:23 PM |
Bizily Scott | Chief Legal and HR Officer | Jun 01, 2023 | Option Exercise | $6.49 | 1,875 | 12,169 | 3,984 | Jun 06, 2023, 07:23 PM |
Bizily Scott | Chief Legal and HR Officer | Jun 01, 2023 | Sale | $18.31 | 2,247 | 41,143 | 1,737 | Jun 06, 2023, 07:23 PM |
Moretti August J | Chief Financial Officer | May 15, 2023 | Option Exercise | $9.41 | 3,000 | 28,230 | 11,045 | May 16, 2023, 08:52 PM |
VIKING GLOBAL INVESTORS LP | 10% Owner | May 09, 2023 | Buy | $16.00 | 850,000 | 13,600,000 | 4,787,914 | May 11, 2023, 05:50 PM |
Bizily Scott | Chief Legal and HR Officer | Apr 21, 2023 | Option Exercise | $8.04 | 3,750 | 30,150 | 5,859 | Apr 25, 2023, 06:44 PM |
Bizily Scott | Chief Legal and HR Officer | Apr 21, 2023 | Sale | $20.00 | 3,750 | 75,000 | 2,109 | Apr 25, 2023, 06:44 PM |
Chacko Jacob | Director | Apr 21, 2023 | Option Exercise | $9.41 | 5,000 | 47,050 | 5,000 | Apr 25, 2023, 06:43 PM |
Chacko Jacob | Director | Apr 21, 2023 | Sale | $20.05 | 5,000 | 100,269 | 0 | Apr 25, 2023, 06:43 PM |
Bizily Scott | Chief Legal and HR Officer | Mar 01, 2023 | Option Exercise | $6.49 | 1,875 | 12,169 | 4,357 | Mar 03, 2023, 06:16 PM |
Bizily Scott | Chief Legal and HR Officer | Mar 01, 2023 | Sale | $19.30 | 2,248 | 43,386 | 2,109 | Mar 03, 2023, 06:16 PM |
Kirn David | Chief Executive Officer | Feb 22, 2023 | Sale | $20.22 | 16,449 | 332,665 | 1,859,153 | Feb 23, 2023, 07:56 PM |
Kirn David | Chief Executive Officer | Feb 21, 2023 | Sale | $20.96 | 17,997 | 377,209 | 1,876,509 | Feb 23, 2023, 07:56 PM |
Kirn David | Chief Executive Officer | Jan 20, 2023 | Sale | $20.19 | 8,625 | 174,127 | 1,893,599 | Jan 23, 2023, 07:57 PM |
Kirn David | Chief Executive Officer | Jan 19, 2023 | Sale | $20.03 | 10,899 | 218,347 | 1,902,224 | Jan 23, 2023, 07:57 PM |
Moretti August J | Chief Financial Officer | Dec 21, 2022 | Option Exercise | $9.41 | 3,000 | 28,230 | 6,595 | Dec 22, 2022, 06:51 PM |
Kirn David | Chief Executive Officer | Dec 15, 2022 | Sale | $23.59 | 32,933 | 776,767 | 1,968,567 | Dec 19, 2022, 05:56 PM |
Kirn David | Chief Executive Officer | Dec 16, 2022 | Sale | $23.02 | 53,944 | 1,241,577 | 1,939,472 | Dec 19, 2022, 05:56 PM |
Bizily Scott | Chief Legal and HR Officer | Dec 01, 2022 | Option Exercise | $7.52 | 5,625 | 42,319 | 6,607 | Dec 05, 2022, 05:33 PM |
Bizily Scott | Chief Legal and HR Officer | Dec 01, 2022 | Sale | $22.79 | 6,000 | 136,725 | 5,607 | Dec 05, 2022, 05:33 PM |
SCHAFFER DAVID | Director | Oct 22, 2021 | Sale | $31.00 | 1,900 | 58,893 | 901,215 | Oct 22, 2021, 09:42 PM |
SCHAFFER DAVID | Director | Oct 21, 2021 | Sale | $31.56 | 22,820 | 720,156 | 903,115 | Oct 22, 2021, 09:42 PM |
SCHAFFER DAVID | Director | Oct 20, 2021 | Sale | $31.02 | 11,565 | 358,771 | 925,935 | Oct 22, 2021, 09:42 PM |
SCHAFFER DAVID | Director | Sep 29, 2021 | Sale | $28.61 | 16,871 | 482,614 | 958,950 | Oct 01, 2021, 04:34 PM |
SCHAFFER DAVID | Director | Sep 30, 2021 | Sale | $26.91 | 12,385 | 333,250 | 942,049 | Oct 01, 2021, 04:34 PM |
SCHAFFER DAVID | Director | Sep 28, 2021 | Sale | $30.53 | 13,912 | 424,693 | 966,856 | Sep 29, 2021, 04:05 PM |
SCHAFFER DAVID | Director | Sep 27, 2021 | Sale | $32.89 | 19,332 | 635,826 | 986,925 | Sep 29, 2021, 04:05 PM |
Moretti August J | Chief Financial Officer | Apr 12, 2021 | Option Exercise | $9.41 | 1,000 | 9,410 | 2,000 | Apr 14, 2021, 04:32 PM |
VIKING GLOBAL INVESTORS LP | 10% Owner | Dec 15, 2020 | Buy | $23.00 | 1,100,000 | 25,300,000 | 3,937,914 | Dec 17, 2020, 09:15 PM |
MILLIGAN JOHN F | Director | Dec 15, 2020 | Buy | $23.00 | 100,000 | 2,300,000 | 100,000 | Dec 17, 2020, 05:40 PM |
Kamal Fariborz | See Remarks | Dec 15, 2020 | Buy | $23.00 | 4,347 | 99,981 | 4,347 | Dec 17, 2020, 05:40 PM |
YAO TONY DUNG LING | Director | Dec 15, 2020 | Buy | $23.00 | 425,000 | 9,775,000 | 1,060,880 | Dec 17, 2020, 05:39 PM |
Load More Insider Transactions
Buy
Sale
Option Exercise
Owner | Relationship | Date | Value($) |
Bizily Scott | Chief Legal Officer | 04/16/2024 | 13,295 |
Bizily Scott | Chief Legal Officer | 04/16/2024 | 45,045 |
Bizily Scott | Chief Legal Officer | 04/01/2024 | 102,224 |
Bizily Scott | Chief Legal Officer | 04/01/2024 | 259,102 |
Bizily Scott | Chief Legal Officer | 03/27/2024 | 151,541 |
Bizily Scott | Chief Legal Officer | 03/27/2024 | 204,410 |
Bizily Scott | Chief Legal Officer | 03/18/2024 | 13,295 |
Bizily Scott | Chief Legal Officer | 03/18/2024 | 54,723 |
Bizily Scott | Chief Legal Officer | 02/27/2024 | 38,638 |
Bizily Scott | Chief Legal Officer | 02/27/2024 | 57,270 |
Bizily Scott | Chief Legal Officer | 02/16/2024 | 13,295 |
Bizily Scott | Chief Legal Officer | 02/16/2024 | 48,423 |
Bizily Scott | Chief Legal Officer | 02/08/2024 | 63,586 |
Bizily Scott | Chief Legal Officer | 02/08/2024 | 171,710 |
Kirn David | Chief Executive Officer | 02/08/2024 | 2,495,822 |
Kim Robert Young | Chief Medical Officer | 02/05/2024 | 366,840 |
Kim Robert Young | Chief Medical Officer | 02/05/2024 | 737,788 |
Kirn David | Chief Executive Officer | 01/23/2024 | 104,851 |
Kirn David | Chief Executive Officer | 01/05/2024 | 552,478 |
Kirn David | Chief Executive Officer | 01/04/2024 | 827,202 |
Kirn David | Chief Executive Officer | 12/18/2023 | 85,243 |
Kirn David | Chief Executive Officer | 12/15/2023 | 494,432 |
VIKING GLOBAL INVESTORS LP | 10% Owner | 01/04/2024 | 10,546,200 |
Bizily Scott | Chief Legal and HR Officer | 06/08/2023 | 30,150 |
Bizily Scott | Chief Legal and HR Officer | 06/08/2023 | 78,188 |
Bizily Scott | Chief Legal and HR Officer | 06/01/2023 | 12,169 |
Bizily Scott | Chief Legal and HR Officer | 06/01/2023 | 41,143 |
Moretti August J | Chief Financial Officer | 05/15/2023 | 28,230 |
VIKING GLOBAL INVESTORS LP | 10% Owner | 05/09/2023 | 13,600,000 |
Bizily Scott | Chief Legal and HR Officer | 04/21/2023 | 30,150 |
Bizily Scott | Chief Legal and HR Officer | 04/21/2023 | 75,000 |
Chacko Jacob | Director | 04/21/2023 | 47,050 |
Chacko Jacob | Director | 04/21/2023 | 100,269 |
Bizily Scott | Chief Legal and HR Officer | 03/01/2023 | 12,169 |
Bizily Scott | Chief Legal and HR Officer | 03/01/2023 | 43,386 |
Kirn David | Chief Executive Officer | 02/22/2023 | 332,665 |
Kirn David | Chief Executive Officer | 02/21/2023 | 377,209 |
Kirn David | Chief Executive Officer | 01/20/2023 | 174,127 |
Kirn David | Chief Executive Officer | 01/19/2023 | 218,347 |
Moretti August J | Chief Financial Officer | 12/21/2022 | 28,230 |
Kirn David | Chief Executive Officer | 12/15/2022 | 776,767 |
Kirn David | Chief Executive Officer | 12/16/2022 | 1,241,577 |
Bizily Scott | Chief Legal and HR Officer | 12/01/2022 | 42,319 |
Bizily Scott | Chief Legal and HR Officer | 12/01/2022 | 136,725 |
SCHAFFER DAVID | Director | 10/22/2021 | 58,893 |
SCHAFFER DAVID | Director | 10/21/2021 | 720,156 |
SCHAFFER DAVID | Director | 10/20/2021 | 358,771 |
SCHAFFER DAVID | Director | 09/29/2021 | 482,614 |
SCHAFFER DAVID | Director | 09/30/2021 | 333,250 |
SCHAFFER DAVID | Director | 09/28/2021 | 424,693 |
SCHAFFER DAVID | Director | 09/27/2021 | 635,826 |
Moretti August J | Chief Financial Officer | 04/12/2021 | 9,410 |
VIKING GLOBAL INVESTORS LP | 10% Owner | 12/15/2020 | 25,300,000 |
MILLIGAN JOHN F | Director | 12/15/2020 | 2,300,000 |
Kamal Fariborz | See Remarks | 12/15/2020 | 99,981 |
YAO TONY DUNG LING | Director | 12/15/2020 | 9,775,000 |
Load More Insider Transactions
FUNDS WITH A POSITION IN 4D MOLECULAR THERAPEUTICS INC
Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
---|---|---|---|---|
RA CAPITAL MANAGEMENT, L.P. | 5,051,511 | 2.06% | 21.34% | Other |
VIKING GLOBAL INVESTORS LP | 2,934,914 | 0.35% | -38.7% | Growth At A Reasonable Price |
BLACKROCK INC. | 4,284,548 | 0.00318% | 23.67% | Other |
GEODE CAPITAL MANAGEMENT, LLC | 872,663 | 0.00257% | 12.14% | Other |
CANDRIAM S.C.A. | 269,000 | 0.05% | 35.86% | Other |
BAKER BROS. ADVISORS LP | 100,000 | 0.04% | New | Other |
RENAISSANCE TECHNOLOGIES LLC | 69,833 | 0.0035% | New | Other |
SOROS FUND MANAGEMENT LLC | 62,500 | 0.03% | New | Other |
D. E. SHAW & CO., INC. | 43,748 | 0.00119% | New | Other |
PLATINUM INVESTMENT MANAGEMENT LTD | 40,767 | 0.05% | New | Growth At A Reasonable Price, Value |
ALPS ADVISORS INC | 35,109 | 0.00792% | 20.93% | Other |
ROYCE & ASSOCIATES LP | 18,769 | 0.00351% | Exited | Value |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 8,821 | 0.00489% | New | Other |
CHANGE IN SHARES OUTSTANDING FOR 4D MOLECULAR THERAPEUTICS INC
STOCK BUYBACKS FOR 4D MOLECULAR THERAPEUTICS INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
Load More
Period of Report: 03/31/2024
10-K/10-Q Filings: View
Previous Period
% Change in Shares
Quarter
12/31/2023
14.94%
1Q
09/30/2023
16.60%
2Q
06/30/2023
28.53%
3Q
12/31/2022
51.65%
5Q
09/30/2022
52.14%
6Q
06/30/2022
52.43%
7Q
03/31/2022
52.86%
8Q
12/31/2021
61.73%
9Q
09/30/2021
82.34%
10Q
06/30/2021
84.27%
11Q
03/31/2021
84.61%
12Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR 4D MOLECULAR THERAPEUTICS INC
LOADING...